Europe Pharmacovigilance Market (2024 - 2030) Size, Share & Trends Analysis Report By Service Provider, By Product Life Cycle, By Therapeutic Area, By Process Flow, By End-use, By Type, By Country, And Segment Forecasts

Market Segmentation

Product Life Cycle Outlook (Revenue, USD Billion, 2018 - 2030)
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
Service Provider Outlook (Revenue, USD Billion, 2018 - 2030)
- In-house
- Contract Outsourcing
Type Outlook (Revenue, USD Billion, 2018 - 2030)
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
End Use Outlook (Revenue, USD Billion, 2018 - 2030)
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
Therapeutic Area Outlook (Revenue, USD Billion, 2018 - 2030)
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Other
Process Flow Outlook (Revenue, USD Billion, 2018 - 2030)
- Case Data Management
- Signal Detection
- Risk Management System
Country Outlook (Revenue, USD Billion, 2018 - 2030)
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Sweden
- Denmark
- Norway

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments